Sharing your medical history and personal experience of living with MBC in a registry could lead to new treatments and improved clinical trial design. Click to read about registries and how they protect your privacy.
While you may have concerns about clinical trials, this month we set the record straight about myths and misconceptions so that you can make an informed decision. Read more here.
You may be interested in learning how a drug goes from being in a clinical trial to being FDA approved. Click the links below to learn more about this process as well as certain circumstances in which a drug can receive faster approval.
You may hear terms like targeted therapy, chemotherapy, hormone therapy, and immunotherapy. Click to learn the difference between these terms and how find trials studying these therapies.
You may hear terms like targeted therapy, chemotherapy, hormone therapy, and immunotherapy. Click to learn the difference between these terms and how find trials studying these therapies.
This month, we continue our series by discussing basket, umbrella, and tumor agnostic trials. Tumor agnostic trials are also called solid tumor trials.
This month, we continue our series by discussing basket, umbrella, and tumor agnostic trials. Tumor agnostic trials are also called solid tumor trials.
This month, we continue our series by discussing trial “arms” and the difference between “control” and “experimental” arms.
This month, we continue our series by discussing dose escalation and dose expansion, terms you may see if you are learning about a phase I trial.
Learn about clinical trial phases, study design, and terms such as randomized, blinded, and open-label.
